Invention Application
- Patent Title: DIAGNOTIC MARKERS
-
Application No.: US14551528Application Date: 2014-11-24
-
Publication No.: US20150086543A1Publication Date: 2015-03-26
- Inventor: Thomas E. Januario , David Shames
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: GENENTECH, INC.
- Current Assignee: GENENTECH, INC.
- Current Assignee Address: US CA South San Francisco
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; A61K31/517
Abstract:
The present invention provides methods of predicting response to a cancer therapy based on the methylation status of the ERBB2 gene. One aspect of the invention provides a method of predicting response to an EGFR inhibitor therapy based on the methylation status of the ERBB2 gene.
Information query
